๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Studies of Pediatric Liver Transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada

โœ Scribed by S. R. Martin; P. Atkison; R. Anand; A. S. Lindblad; The SPLIT Research Group

Book ID
110895741
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
138 KB
Volume
8
Category
Article
ISSN
1397-3142

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The pediatric end-stage liver disease (P
The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients
โœ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

Portal vein thrombosis and outcomes for
Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States
โœ Seth A. Waits; Brandon M. Wojcik; Shijie Cai; Amit K. Mathur; Michael J. Englesb ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB ๐Ÿ‘ 1 views

The effect of occlusive portal vein thrombosis (PVT) on the mortality of pediatric liver transplant candidates and recipients is poorly defined. Using standard multivariate techniques, we studied the relationship between PVT and waiting-list and posttransplant survival rates with data from the Scien

Patient and graft survival in hepatitis
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States
โœ Mark W. Russo; Joseph Galanko; Kimberly Beavers; Michael W. Fried; Roshan Shrest ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 1 views

End stage liver disease from chronic hepatitis C is the leading indication for liver transplantation in the United States. Small studies suggest that recurrent hepatitis C may be more common and occur earlier after living donor liver transplantation compared to deceased donor liver transplantation.